Can we predict which kids will benefit from CF drugs?
NCT ID NCT07148739
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how new cystic fibrosis drugs work in children ages 2 and older. Researchers want to find genetic clues that can tell us ahead of time who will respond well, so kids don't get unnecessary side effects or high costs from treatments that won't help them. About 100 participants will have their drug levels checked and answer questionnaires about their mental health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Arkansas Children's Hospital
RECRUITINGLittle Rock, Arkansas, 72205, United States
-
The University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35233, United States
-
University of Washington
RECRUITINGSeattle, Washington, 98195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist
- Can a smartphone app reveal how CF treatments really work at home?
- Breathing vs. beating: which technique clears lungs better in cystic fibrosis?
- Can a peer coach help young people take control of their chronic illness?
- Could modern CF drugs make daily inhaled treatments obsolete?
- New study investigates hidden heart risks in cystic fibrosis patients on modern drugs